These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14281371)

  • 1. THE EFFECT OF SF 20-10-5 CONCENTRATION CHANGES INDUCED BY ETHYL CHLOROPHENOXYISOBUTYRATE ON HIGH-DENSITY LIPOPROTEIN LIPID COMPOSITION.
    STRISOWER EH; NICHOLS AV; LINDGREN FT; SMITH L
    J Lab Clin Med; 1965 May; 65():748-55. PubMed ID: 14281371
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES WITH ETHYL CHLOROPHENOXYISOBUTYRATE (CLOFIBRATE).
    AZARNOFF DL; TUCKER DR; BARR GA
    Metabolism; 1965 Sep; 14():959-65. PubMed ID: 14327272
    [No Abstract]   [Full Text] [Related]  

  • 3. A COMPARISON OF THE EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE AND NICOTINIC ACID ON PLASMA FREE FATTY ACIDS.
    DUNCAN CH; BEST MM; ROBERTSON GL
    Lancet; 1965 Jan; 1(7378):191-3. PubMed ID: 14238047
    [No Abstract]   [Full Text] [Related]  

  • 4. HYPOLIPEMIA AND HEPATOMEGALY FROM ETHYL CHLOROPHENOXYISOBUTYRATE (CPIB) IN THE RAT.
    BEST MM; DUNCAN CH
    J Lab Clin Med; 1964 Oct; 64():634-42. PubMed ID: 14233152
    [No Abstract]   [Full Text] [Related]  

  • 5. STUDIES OF THE METABOLISM OF RADIOIODINATED HUMAN SERUM ALPHA LIPOPROTEIN IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
    FURMAN RH; SANBAR SS; ALAUPOVIC P; BRADFORD RH; HOWARD RP
    J Lab Clin Med; 1964 Feb; 63():193-204. PubMed ID: 14125106
    [No Abstract]   [Full Text] [Related]  

  • 6. THE SEPARATE HYPOLIPOPROTEINEMIC EFFECTS OF DEXTROTHYROXINE AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH; STRISOWER B
    J Clin Endocrinol Metab; 1964 Feb; 24():139-44. PubMed ID: 14123837
    [No Abstract]   [Full Text] [Related]  

  • 7. EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE, ALONE OR WITH ANDROSTERONE (ATROMID) ON SERUM LIPIDS, LIPOPROTEINS AND RELATED METABOLIC PARAMETERS IN NORMAL AND HYPERLIPIDEMIC SUBJECTS.
    HOWARD RP; ALAUPOVIC P; BRUSCO OJ; FURMAN RH
    J Atheroscler Res; 1963; 3():482-99. PubMed ID: 14100889
    [No Abstract]   [Full Text] [Related]  

  • 8. THE RESPONSE OF HYPERLIPOPROTEINEMIAS TO ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE.
    STRISOWER EH
    J Atheroscler Res; 1963; 3():445-53. PubMed ID: 14100885
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF ATROMID ON PLASMA LIPIDS AND LIPROPROTEINS IN SUBJECTS WITH HYPERLIPOPROTEINEMIA. (A PRELIMINARY REPORT).
    CARLSON LA; HOEGSTEDT B; OROE L
    J Atheroscler Res; 1963; 3():467-74. PubMed ID: 14100887
    [No Abstract]   [Full Text] [Related]  

  • 10. THE EFFECTS OF ATROMID ON THE ALPHA-BETA-LIPOPROTEIN RATIO IN CORONARY DISEASE.
    KERNOHAN RJ; NEELY RA
    J Atheroscler Res; 1963; 3():518-24. PubMed ID: 14100892
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate.
    THORP JM; WARING WS
    Nature; 1962 Jun; 194():948-9. PubMed ID: 13921051
    [No Abstract]   [Full Text] [Related]  

  • 12. ACTION OF ATROMID ON SERUM LIPIDS AND ON BETA-LIPOPROTEIN LIPIDS AND PROTEIN.
    CRAMER K
    J Atheroscler Res; 1963; 3():500-8. PubMed ID: 14100890
    [No Abstract]   [Full Text] [Related]  

  • 13. METABOLISM AND FUNCTION OF PHOSPHOLIPIDS AND SPHINGOLIPIDS.
    RODSSITER RJ
    Clin Chem; 1965 Feb; 11():SUPPL:171-93. PubMed ID: 14256870
    [No Abstract]   [Full Text] [Related]  

  • 14. PLASMA AND TISSUE LIPIDS IN HYPERCHOLESTEREMIC PIGEONS.
    BANERJEE S; RAO PN; BANDYOPADHYAY A
    Proc Soc Exp Biol Med; 1965 May; 119():150-3. PubMed ID: 14297832
    [No Abstract]   [Full Text] [Related]  

  • 15. THE EFFECT OF ETHYL CHLOROPHENOXYISOBUTYRATE ON THE BINDING BETWEEN TRIIODOTHYRONINE AND PROTEIN.
    MOGENSEN EF
    J Atheroscler Res; 1963; 3():415-7. PubMed ID: 14100882
    [No Abstract]   [Full Text] [Related]  

  • 16. REDUCTION OF SERUM CHOLESTEROL AND LIPIDS BY ETHYL CHLOROPHENOXYISOBUTYRATE.
    HELLMAN L; ZUMOFF B; KESSLER G; KARA E; RUBIN IL; ROSENFELD RS
    J Atheroscler Res; 1963; 3():454-66. PubMed ID: 14100886
    [No Abstract]   [Full Text] [Related]  

  • 17. SERUM LIPID AND LIPOPROTEIN CHANGES AFTER TREATMENT WITH ATROMID IN PATIENTS WITH ATHEROSCLEROSIS, ESSENTIAL HYPERLIPAEMIA AND FAMILIAL HYPERCHOLESTEROLAEMIA.
    FASOLI A; CESANA A
    J Atheroscler Res; 1963; 3():475-81. PubMed ID: 14100888
    [No Abstract]   [Full Text] [Related]  

  • 18. BETA-LIPOPROTEIN, LIPOPROTEIN LIPASE AND ATROMID.
    HOOD B; BEDDING P; CARLANDER B
    J Atheroscler Res; 1963; 3():509-17. PubMed ID: 14100891
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES ON LOW-DENSITY LIPOPROTEIN TURNOVER IN RELATION TO ATROMID THERAPY.
    WALTON KW; SCOTT PJ; VERRIERJONES J; FLETCHER RF; WHITEHEAD T
    J Atheroscler Res; 1963; 3():396-414. PubMed ID: 14100881
    [No Abstract]   [Full Text] [Related]  

  • 20. PREVENTION OF THE ACUTE ETHANOL-INDUCED FATTY LIVER BY THE SIMULTANEOUS ADMINISTRATION OF ANTIOXIDANTS.
    DILUZIO NR
    Life Sci (1962); 1964 Feb; 3():113-8. PubMed ID: 14148131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.